Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Arlene Siefker-Radtke: ASCO GU highlights

Arlene Siefker-Radtke, MD, University of Texas MD Anderson Cancer Center, Houston, TX, gives her opinion on the key bladder cancer data from this meeting. Specifically, she focuses on nintedanib showing improved progression-free survival and overall survival in a subset of patients. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.